A prospective, single-arm, phase II exploratory clinical study on the efficacy and safety of neoadjuvant adebrelimab combined with cisplatin and docetaxel in patients with clinical stage IVB oral squamous cell carcinoma.
Zi-Li Yu, Nian‐Nian Zhong, Gaili Chen, Tian-Fu Wu et autres
6048 Background: Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumors of the head and neck. Stage IVB OSCC had long been considered unresectable with extremely poor prognosis, and mainstream guidelines encourage exploring new therapies via clinical trials. …
cn (code pays fourni par la source)
0 citations
Journal of Clinical Oncology